Skip to Content
  • 2.6
    Impact Factor
  • 4.2
    CiteScore
  • 37 days
    Submission to First Decision
  • 7 days
    Acceptance to Publication

Infectious Disease Reports

Infectious Disease Reports is an international, peer-reviewed, open access journal on infectious diseases published bimonthly online by MDPI (since Volume 12, Issue 3 - 2020).

Get Alerted

Add your email address to receive forthcoming issues of this journal.

All Articles (923)

  • Article
  • Open Access

Background/Objectives: Ventilator-associated pneumonia (VAP) is a major indication for antibiotic therapy in intensive care units (ICUs), and patients with traumatic brain injury (TBI) are at particularly high risk of early-onset VAP (eVAP). Prophylaxis reduces eVAP but may select multidrug-resistant (MDR) organisms. We assessed whether prophylactic exposure beyond 24 h was associated with eVAP and with MDR aetiology of the subsequent episode. Methods: This study involved a retrospective single-centre cohort of adults with moderate-to-severe TBI (Glasgow Coma Scale ≤ 12) on invasive mechanical ventilation in a Brazilian reference trauma ICU (January–August 2016). Patients were grouped by prophylactic exposure during the first 24 h of ICU admission: no recorded prophylaxis or a single recorded administration (short-course group) versus prophylaxis documented for ≥24 consecutive hours (prolonged group); because administration times were documented in whole days, these categories reflect recorded rather than directly measured exposure. The primary outcome was eVAP (48–96 h of ventilation); secondary outcomes included MDR or extensively drug-resistant (XDR) aetiology of the first episode, tracheostomy, mortality and neurological outcome. Multivariable logistic regression with backward selection was complemented by a pre-specified forced-entry model. Results: Of 907 admissions, 231 were included (123 short-course; 108 prolonged). The prolonged group had less eVAP (19.4% versus 36.6%; adjusted odds ratio [OR] 0.47, 95% CI 0.25–0.87; forced-entry model OR 0.51, 95% CI 0.26–0.99). Among the 97 patients with quantitative culture confirmation of the first VAP episode, MDR/XDR organisms were more frequent in the prolonged group than in the short-course group (48.6% versus 27.4%; adjusted OR 3.23, 95% CI 1.27–8.33); this estimate rests on 34 resistant episodes and is exploratory. Mortality and neurological outcome did not differ. Conclusions: Prolonged prophylactic exposure was associated with less eVAP but with a higher proportion of resistant organisms among culture-confirmed episodes. These observational findings are hypothesis-generating; they do not establish causality or identify an optimal duration, and support prospective evaluation of short-course strategies.

Infect. Dis. Rep.

12 November 2026

Flow diagram of patient inclusion in the study. Exclusion criteria were not mutually exclusive; the three most frequent are shown individually. GCS, Glasgow Coma Scale; ICU, intensive care unit.
  • Review
  • Open Access

Background: The Democratic Republic of the Congo (DRC) has extensive experience responding to Ebola disease outbreaks; however, the emergence of Bundibugyo virus (BDBV) presents distinct operational challenges because its epidemiological evidence base and the available medical countermeasures are more limited than those for Zaire ebolavirus. The 2026 outbreak has been characterized by substantial transmission in Ituri Province, with reported activity in additional provinces. Operational challenges include incomplete contact follow-up, community deaths, health-system constraints, population mobility, insecurity and gaps in infection prevention and control (IPC). These challenges highlight the need for an adaptable framework that links case investigation, surveillance, IPC and community engagement. Objective: To describe the epidemiological and operational situation of the 2026 BDBV outbreak and develop a conceptual ring-oriented surveillance and IPC framework for organizing outbreak-response activities in Ituri Province, informed by evidence from previous Ebola outbreaks. Methods: A secondary descriptive situation analysis was undertaken using the outbreak situation report for the reporting period ending 11 August 2026, supplemented by a targeted narrative review of the published literature and relevant Ebola outbreak-response guidance. The reported indicators were descriptively summarized, including cases, deaths, alerts, laboratory testing, contact identification and follow-up, IPC activities and population-mobility surveillance. A conceptual Ring 0–Ring 5 framework was developed based on epidemiological proximity and operational connectivity. Ring 0 represents the suspected or confirmed case and immediate care environment; Ring 1 represents direct contacts; Ring 2 represents contacts of contacts and epidemiologically linked exposures; Ring 3 represents high-risk community settings; Ring 4 represents health-system and population-mobility interfaces; and Ring 5 represents regional and cross-border preparedness. The framework incorporates continuous monitoring with escalation, de-escalation or closure according to emerging epidemiological information. Results: By 11 August 2026, the situation report documented 4566 confirmed cases and 2128 confirmed deaths, with 3912 cases (85.7%) reported from Ituri. During the preceding 24 h reporting period, 118 new confirmed cases and 67 deaths were reported. Nationally, 20,728 contacts were identified and 17,085 followed (82.4%). A total of 1542 alerts were received, 1423 verified and 324 classified as suspected cases; 516 specimens were analysed, including 118 positive results. The proposed framework organizes these reported activities sequentially from case detection and immediate IPC (Ring 0), direct-contact investigation and monitoring (Ring 1), linked-exposure surveillance (Ring 2), community-level IPC and engagement (Ring 3), health-system and mobility surveillance (Ring 4), to regional and cross-border preparedness (Ring 5). Continuous epidemiological reassessment provides feedback for intensifying, expanding, de-escalating or closing response activities. Conclusions: The 2026 BDBV outbreak demonstrates the need for coordinated surveillance, case investigation, contact monitoring, IPC, clinical referral, safe and dignified burial, community engagement and health-system preparedness. The proposed ring-oriented surveillance and IPC framework provides a structured and adaptable approach for linking these activities according to epidemiological risk and operational connectivity. However, the present analysis is descriptive and conceptual and does not establish the effectiveness, feasibility or acceptability of the framework. Prospective implementation research is required to evaluate feasibility, acceptability, implementation fidelity and epidemiological effectiveness.

Infect. Dis. Rep.

16 November 2026

  • Review
  • Open Access

Rabies remains an invariably fatal encephalitis claiming approximately 59,000 human lives annually, with the burden concentrated in low- and middle-income countries of Asia and Africa. Prevention depends almost exclusively upon vaccination and post-exposure prophylaxis (PEP) regimens that elicit virus-neutralizing antibodies directed against the viral glycoprotein (G). This review synthesizes recent advances in rabies virus (RABV) genomics and structural virology with particular emphasis upon the G ectodomain, the sole surface-exposed viral component and the primary immunological target of protective immunity. This review examines the RABV evolution across phylogenetically distinct lyssavirus lineages, the molecular determinants of virulence and neuroinvasiveness encoded within the G gene, and structural characterization of the ectodomain by contemporary cryo-electron microscopy and crystallography. High-resolution structural studies have resolved the quaternary organization of the prefusion trimer engaged by neutralizing antibodies, indicating that the conformational stability of these epitopes is an important determinant of vaccine-induced immunity, and cryo-electron microscopy of nine antibody complexes reported in 2026 has extended the antigenic map to six sites, two of them newly defined, unusually well conserved across lyssaviruses and recognized by the most broadly cross-reactive antibodies yet described. The applied literature is then organized around the three translational uses of the protein: its diagnostic application in ectodomain-based serology and antigen detection, its therapeutic application in monoclonal antibody cocktails replacing serum-derived immunoglobulin, and its vaccinal application across inactivated, subunit, virus-like particle, vectored, and nucleic acid platforms. Ectodomain architecture therefore underpins next-generation vaccines, improved post-exposure therapeutics and diagnostics, and with them the global target of zero human deaths from dog-mediated rabies by 2030.

Infect. Dis. Rep.

11 November 2026

  • Case Report
  • Open Access

Background: Lautropia mirabilis is an uncommon Gram-negative facultative anaerobic bacterium primarily colonizing the oral cavity and upper respiratory tract. Peritoneal dialysis-associated peritonitis (PDAP) caused by this organism is exceedingly rare, with only three previously published cases. Case presentation: We report a 49-year-old woman receiving continuous ambulatory peritoneal dialysis who presented with cloudy dialysate and abdominal pain. Peritoneal effluent analysis revealed a leukocyte count of 16,522 cells/µL, with 85% polymorphonuclear leukocytes, accompanied by an elevated serum C-reactive protein level of 42.77 mg/L. L. mirabilis was isolated from the dialysate and identified using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and 16S rRNA gene sequencing. Following intraperitoneal antimicrobial treatment with gentamicin and subsequently ceftazidime, the patient’s symptoms improved. No recurrence of peritonitis was documented during follow-up. A review of the three previously reported cases highlights similarities in clinical presentation but differences in microbiological identification and antimicrobial management. Conclusions: L. mirabilis should be recognized as a potential, albeit rare, cause of PDAP. This case highlights the value of appropriate culture conditions combined with molecular identification for detecting unusual pathogens and emphasizes the importance of integrating microbiological findings with clinical and laboratory responses when guiding treatment.

Infect. Dis. Rep.

11 November 2026

Highly Accessed Articles

News & Conferences

Latest Issues

Open for Submission

Journal Sections

XFacebookLinkedIn
Infect. Dis. Rep. - ISSN 2036-7449